Avita Medical Net Income
| RCEL Stock | USD 4.16 0.44 11.83% |
As of the 17th of February 2026, Avita Medical shows the Risk Adjusted Performance of 0.0375, downside deviation of 2.73, and Mean Deviation of 2.48. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Avita Medical, as well as the relationship between them. Please confirm Avita Medical jensen alpha, as well as the relationship between the potential upside and skewness to decide if Avita Medical is priced correctly, providing market reflects its regular price of 4.16 per share. Given that Avita Medical has jensen alpha of 0.1024, we suggest you to validate Avita Medical's prevailing market performance to make sure the company can sustain itself at a future point.
Avita Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 2.0607 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -48.6 M | -46.2 M | |
| Net Loss | -48.6 M | -46.2 M | |
| Net Loss | -24 M | -25.2 M | |
| Net Loss | (1.74) | (1.83) | |
| Net Income Per E B T | 1.00 | 1.56 |
Avita | Net Income | Build AI portfolio with Avita Stock |
Historical Net Income data for Avita Medical serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Avita Medical represents a compelling investment opportunity.
Latest Avita Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Avita Medical over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Avita Medical financial statement analysis. It represents the amount of money remaining after all of Avita Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Avita Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avita Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (48.59 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Avita Net Income Regression Statistics
| Arithmetic Mean | (22,680,093) | |
| Coefficient Of Variation | (75.82) | |
| Mean Deviation | 13,356,359 | |
| Median | (24,624,077) | |
| Standard Deviation | 17,195,667 | |
| Sample Variance | 295.7T | |
| Range | 61.6M | |
| R-Value | (0.92) | |
| Mean Square Error | 47T | |
| R-Squared | 0.85 | |
| Slope | (3,141,087) | |
| Total Sum of Squares | 4731.1T |
Avita Net Income History
Other Fundumenentals of Avita Medical
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Avita Medical Net Income component correlations
Avita Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Avita Medical is extremely important. It helps to project a fair market value of Avita Stock properly, considering its historical fundamentals such as Net Income. Since Avita Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Avita Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Avita Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. Anticipated expansion of Avita directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Avita Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.81) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
Investors evaluate Avita Medical using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Avita Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Avita Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Avita Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Avita Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Avita Medical's market price signifies the transaction level at which participants voluntarily complete trades.
Avita Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Avita Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Avita Medical.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Avita Medical on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Avita Medical or generate 0.0% return on investment in Avita Medical over 90 days. Avita Medical is related to or competes with InspireMD, Hyperfine, Vivani Medical, Quipt Home, Apyx Medical, Xtant Medical, and Ovid Therapeutics. AVITA Medical, Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the ... More
Avita Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Avita Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Avita Medical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.73 | |||
| Information Ratio | 0.0169 | |||
| Maximum Drawdown | 17.83 | |||
| Value At Risk | (4.00) | |||
| Potential Upside | 6.67 |
Avita Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Avita Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Avita Medical's standard deviation. In reality, there are many statistical measures that can use Avita Medical historical prices to predict the future Avita Medical's volatility.| Risk Adjusted Performance | 0.0375 | |||
| Jensen Alpha | 0.1024 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.0215 | |||
| Treynor Ratio | 0.4387 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Avita Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Avita Medical February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0375 | |||
| Market Risk Adjusted Performance | 0.4487 | |||
| Mean Deviation | 2.48 | |||
| Semi Deviation | 2.48 | |||
| Downside Deviation | 2.73 | |||
| Coefficient Of Variation | 2704.71 | |||
| Standard Deviation | 3.48 | |||
| Variance | 12.1 | |||
| Information Ratio | 0.0169 | |||
| Jensen Alpha | 0.1024 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.0215 | |||
| Treynor Ratio | 0.4387 | |||
| Maximum Drawdown | 17.83 | |||
| Value At Risk | (4.00) | |||
| Potential Upside | 6.67 | |||
| Downside Variance | 7.44 | |||
| Semi Variance | 6.13 | |||
| Expected Short fall | (3.16) | |||
| Skewness | 1.44 | |||
| Kurtosis | 3.19 |
Avita Medical Backtested Returns
As of now, Avita Stock is moderately volatile. Avita Medical secures Sharpe Ratio (or Efficiency) of 0.0412, which signifies that the company had a 0.0412 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Avita Medical, which you can use to evaluate the volatility of the firm. Please confirm Avita Medical's Mean Deviation of 2.48, downside deviation of 2.73, and Risk Adjusted Performance of 0.0375 to double-check if the risk estimate we provide is consistent with the expected return of 0.15%. Avita Medical has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.27, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Avita Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Avita Medical is expected to be smaller as well. Avita Medical right now shows a risk of 3.57%. Please confirm Avita Medical sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Avita Medical will be following its price patterns.
Auto-correlation | -0.76 |
Almost perfect reverse predictability
Avita Medical has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Avita Medical time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Avita Medical price movement. The serial correlation of -0.76 indicates that around 76.0% of current Avita Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.76 | |
| Spearman Rank Test | -0.39 | |
| Residual Average | 0.0 | |
| Price Variance | 0.16 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Avita Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Avita Medical reported net income of (48.59 Million). This is 114.24% lower than that of the Biotechnology sector and 120.41% lower than that of the Health Care industry. The net income for all United States stocks is 108.51% higher than that of the company.
Avita Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avita Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avita Medical could also be used in its relative valuation, which is a method of valuing Avita Medical by comparing valuation metrics of similar companies.Avita Medical is currently under evaluation in net income category among its peers.
Avita Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Avita Medical from analyzing Avita Medical's financial statements. These drivers represent accounts that assess Avita Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Avita Medical's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 291.8M | 165.0M | 347.5M | 331.3M | 96.1M | 182.0M | |
| Enterprise Value | 237.9M | 147.8M | 367.8M | 363.2M | 88.0M | 107.3M |
Avita Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Avita Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Avita Medical's managers, analysts, and investors.Environmental | Governance | Social |
Avita Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Avita Medical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Avita Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Avita Medical's value.| Shares | Goldman Sachs Group Inc | 2025-06-30 | 93.7 K | Jane Street Group Llc | 2025-06-30 | 86.7 K | Charles Schwab Investment Management Inc | 2025-06-30 | 85.8 K | Marshall Wace Asset Management Ltd | 2025-06-30 | 76.8 K | Bank Of America Corp | 2025-06-30 | 62.6 K | D. E. Shaw & Co Lp | 2025-06-30 | 62 K | Nuveen, Llc | 2025-06-30 | 59.3 K | Citadel Advisors Llc | 2025-06-30 | 58.8 K | Bank Of New York Mellon Corp | 2025-06-30 | 55.3 K | Blackrock Inc | 2025-06-30 | 1.9 M | Vanguard Group Inc | 2025-06-30 | 1.5 M |
Avita Fundamentals
| Return On Equity | -17.46 | ||||
| Return On Asset | -0.39 | ||||
| Profit Margin | (0.68) % | ||||
| Operating Margin | (0.59) % | ||||
| Current Valuation | 149.19 M | ||||
| Shares Outstanding | 30.63 M | ||||
| Shares Owned By Insiders | 0.79 % | ||||
| Shares Owned By Institutions | 16.77 % | ||||
| Number Of Shares Shorted | 3.77 M | ||||
| Price To Book | 11.77 X | ||||
| Price To Sales | 1.78 X | ||||
| Revenue | 71.61 M | ||||
| Gross Profit | 58.82 M | ||||
| EBITDA | 63.74 M | ||||
| Net Income | (48.59 M) | ||||
| Cash And Equivalents | 84.17 M | ||||
| Cash Per Share | 0.67 X | ||||
| Total Debt | 2.13 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 9.64 X | ||||
| Book Value Per Share | (0.55) X | ||||
| Cash Flow From Operations | (31.2 M) | ||||
| Short Ratio | 17.27 X | ||||
| Earnings Per Share | (1.81) X | ||||
| Price To Earnings To Growth | (0.04) X | ||||
| Target Price | 8.56 | ||||
| Number Of Employees | 226 | ||||
| Beta | 1.8 | ||||
| Market Capitalization | 127.43 M | ||||
| Total Asset | 56.39 M | ||||
| Retained Earnings | (408.4 M) | ||||
| Working Capital | (27.19 M) | ||||
| Net Asset | 56.39 M |
About Avita Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avita Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avita Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avita Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. Anticipated expansion of Avita directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Avita Medical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.81) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
Investors evaluate Avita Medical using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Avita Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Avita Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Avita Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Avita Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Avita Medical's market price signifies the transaction level at which participants voluntarily complete trades.